ITGAM and neoplasm: However, we did not observe significant changes in the levels of mature inflammatory monocytes (CD11b+F4/80+Ly6C+) and the immature myeloid population (CD11b+Ly6G−Ly6C+) in spleen, tumor, and dLNs after treatment with the combination (data not shown).